- Forums
- ASX - By Stock
- SGR
- Ann: Appendix 4D & 2023 Half-Year Financial Report
Ann: Appendix 4D & 2023 Half-Year Financial Report, page-50
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGR (ASX) to my watchlist
|
|||||
Last
49.3¢ |
Change
-0.013(2.48%) |
Mkt cap ! $1.412B |
Open | High | Low | Value | Volume |
50.0¢ | 50.5¢ | 49.0¢ | $1.103M | 2.228M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1288460 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 611984 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
63 | 1248266 | 0.490 |
30 | 922258 | 0.485 |
53 | 1302235 | 0.480 |
25 | 1696196 | 0.475 |
27 | 831077 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 554254 | 39 |
0.500 | 732804 | 30 |
0.505 | 612560 | 17 |
0.510 | 879356 | 25 |
0.515 | 750925 | 21 |
Last trade - 12.08pm 16/07/2024 (20 minute delay) ? |
Featured News
SGR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online